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Expansion of a hexanucleotide (GGGGCC) repeat in the gene chromosome 9 open
reading frame 72 (C9ORF72) is the most common cause of amyotrophic lateral
sclerosis and frontotemporal dementia (FTD). Three non-exclusive mechanisms have
been proposed to contribute to the pathology initiated by this genetic insult. First, it was
suggested that decreased expression of the C9orf72 protein product may contribute
to disease. Second, the recognition that C9ORF72-related disease is associated with
accumulation of GGGGCC repeat-containing RNA in nuclear foci led to the suggestion
that toxic gain of RNA function, perhaps related to sequestration of RNA-binding
proteins, might be an important driver of disease. Third, it was subsequently appreciated
that GGGGCC repeat-containing RNA undergoes unconventional translation to produce
unnatural dipeptide repeat (DPR) proteins that accumulate in patient brain early
in disease. DPRs translated from all six reading frames in either the sense or
antisense direction of the hexanucleotide repeat result in the expression of five DPRs:
glycine–alanine (GA), glycine–arginine (GR), proline–alanine (PA), proline–arginine (PR)
and glycine–proline (GP; GP is generated from both the sense and antisense reading
frames). However, the relative contribution of each DPR to disease pathogenesis
remains unclear. Here, we review evidence for the contribution of each specific DPR
to pathogenesis and examine the probable mechanisms through which these DPRs
induce neurodegeneration. We also consider the association of the toxic DPRs with
impaired RNA metabolism and alterations to the liquid-like state of non-membrane-
bound organelles.
Keywords: amyotrophic lateral sclerosis, C9orf72, dipeptide repeat, frontotemporal dementia, liquid–liquid phase
separation, nuclear pore, nucleocytoplasmic transport, RNA metabolism
INTRODUCTION
The seminal discovery of a GGGGCC hexanucleotide repeat expansion within chromosome
9 open reading frame 72 (C9ORF72) in 2011 represented a major advance in neurodegenerative
disease research by revealing the most common genetic insult responsible for the development of
amyotrophic lateral sclerosis (ALS) and/or frontotemporal dementia (FTD) (DeJesus-Hernandez
et al., 2011; Renton et al., 2011; Majounie et al., 2012). The expansion occurs within the noncoding
region between exons 1a and 1b of C9ORF72; therefore, the expansion occurs in either the first
intron or the promoter region of the gene, depending on which of the two alternative transcription
start sites is used (DeJesus-Hernandez et al., 2011). Healthy individuals have been described as
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having up to 23 hexanucleotide repeats, although most carry
between two and eight repeats (DeJesus-Hernandez et al., 2011;
Renton et al., 2011). Patients with C9orf72-mediated ALS/FTD
have greater than 30 hexanucleotide repeats, but repeats that are
thousands of base pairs long are common.
Two distinct, though non-exclusive, hypotheses initially
described the mechanisms by which this expansion causes
disease: (1) loss of function due to decreased expression
of the C9orf72 protein; and (2) gain of function due to
the accumulation of toxic RNA foci (Taylor et al., 2016).
Supporting the loss-of-function hypothesis was the observation
that the hexanucleotide repeat expansion leads to modestly
decreased protein expression of C9orf72 in both cell culture and
affected tissues (DeJesus-Hernandez et al., 2011; Renton et al.,
2011; Gijselinck et al., 2012; Belzil et al., 2013). More recent
evidence has emerged from studies of C9orf72-null mice, which
display an age-related inflammatory response in macrophages
and microglia, suggesting that loss of C9orf72 protein could
potentially contribute in a non-cell autonomous manner to
the neurodegeneration observed in patients with ALS/FTD
(O’Rourke et al., 2016). However, selective removal of C9orf72
from neurons does not lead to neurodegeneration or motor
defects, suggesting that loss of protein function plays an auxiliary
role in the pathogenesis of ALS/FTD (Koppers et al., 2015;
O’Rourke et al., 2016).
The accumulation of RNA foci (Figure 1) found
predominantly in the nuclei of affected cells was observed
concomitant with the discovery of the expanded GGGGCC
repeat (DeJesus-Hernandez et al., 2011). Shortly thereafter, it was
observed that bidirectional transcription of the expanded repeat
leads to the formation of antisense RNA foci (Gendron et al.,
2013; Mizielinska et al., 2013). More detailed in vitro studies
revealed that the GGGGCC repeat adopts a G-quadruplex
structure (i.e., a tertiary structure formed by guanine-tetrad
stacking), although it remains unclear whether the G-quadruplex
is the predominant structure found in sense or antisense RNA
foci in vivo (Fratta et al., 2012; Reddy et al., 2013). Linking
these RNA foci to toxicity, the prevailing gain-of-function
hypothesis posits that RNA foci sequester RNA-binding
proteins, leading to disruptions in RNA metabolism. Indeed,
antisense oligonucleotides directed against the sense strand of
the repeat mitigate pathology in an induced pluripotent stem cell
model of disease (Donnelly et al., 2013).
The third and most recent non-exclusive hypothesis linking
the C9orf72 expansion to pathogenesis is based on the
phenomenon of repeat-associated non-ATG (RAN) translation,
a type of unconventional translation first observed in the
microsatellite expansion disease spinocerebellar ataxia type 8
(Zu et al., 2011). This observation led to interrogation of
potential RAN translation of C9orf72, which was confirmed by
the observation of dipeptide repeats (DPRs) translated from both
the sense and antisense strands of the expanded hexanucleotide
repeats. From the six reading frames that undergo RAN
translation, five distinct DPRs are generated: glycine-alanine
(GA) and glycine-arginine (GR) DPRs from the sense RNA
strand; proline-alanine (PA) and proline-arginine (PR) from the
antisense strand; and glycine-proline (GP) translated from both
the sense and antisense strands (Mori et al., 2013a,c; Zu et al.,
2013).
The relative pathogenic contributions of loss of
C9orf72 protein expression, RNA foci-mediated toxicity,
and RAN-generated DPR toxicity remain obscure. However,
strong evidence has demonstrated that DPRs are toxic in both
cell culture and animal models of disease. However, the relative
contribution of each DPR to pathogenesis remains disputed.
In this review article, we summarize the current knowledge
of the individual contribution of specific DPRs to disease
progression and provide a framework for understanding the
potential mechanisms by which these DPRs produce their toxic
phenotypes.
FIGURE 1 | RNA and DPR pathology in C9orf72 mediated ALS/FTD. RNA foci in the nucleus (arrows) and the cytoplasm (arrowhead) of a chromosome 9 open
reading frame 72 (C9orf72) amyotrophic lateral sclerosis frontotemporal dementia (ALS/FTD) cortical neuron (left). Glycine-alanine (GA; middle) and glycine-arginine
(GR; right) dipeptide repeat (DPR) pathology in the dentate nucleus of a C9orf72 ALS/FTD affected brain. Adapated from Taylor et al. (2016).
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DIPEPTIDE REPEAT PATHOLOGY
A unique pathologic hallmark of C9orf72-mediated disease is the
presence of star-shaped cytoplasmic inclusions in both neurons
and glia (Figure 1) (Ash et al., 2013; Mann et al., 2013; Mori et al.,
2013a,c; Schludi et al., 2015). These inclusions are negative for
TDP-43 but positive for p62, ubiquitin, and the five DPR species
generated by RAN translation of the hexanucleotide repeat;
however, patients also display prominent TDP-43 pathology
in degenerating regions of the brain and spinal cord. DPR
inclusions have been identified in the hippocampus, basal
ganglia, frontal cortex, cerebellum and motor cortex in patients
with ALS/FTD (Al-Sarraj et al., 2011; Cooper-Knock et al., 2012;
Hsiung et al., 2012; Mahoney et al., 2012; Troakes et al., 2012).
The inclusions are also present, albeit in reduced quantities,
in the spinal cord (Gomez-Deza et al., 2015; Schipper et al.,
2016). DPR pathology in addition to RNA foci have also been
observed in transgenic mouse models of C9orf72-mediated
disease with varying degrees of associated neurodegeneration
(O’Rourke et al., 2015; Peters et al., 2015; Jiang et al., 2016; Liu
et al., 2016).
Although the large p62-positive cytoplasmic aggregates are
the most prominent feature in the frontal cortex of patients
with C9orf72-mediated disease, intranuclear aggregates have also
been described. Studies of post-mortem tissue have reported
p62-negative para-nucleolar aggregates (Schludi et al., 2015),
as well as PR DPR localization in nucleophosmin-positive
intranuclear inclusions (Wen et al., 2014), suggesting that
nucleolar localization of DPR-containing aggregates occurs in
C9orf72-mediated disease. Importantly, multiple reports indicate
that DPR pathology appears early in disease, perhaps years
before the accrual of TDP-43 pathology (Baborie et al., 2015;
Vatsavayai et al., 2016). In some instances a lack of correlation
has been described between the regional burden of DPR
proteins and the corresponding severity of neurodegeneration,
raising questions about their relative contribution to disease
(Mackenzie et al., 2013; Davidson et al., 2014). However,
these studies were based on the post-mortem examination
of brains with end-stage disease and relied on the detection
of large inclusions using immunohistochemistry, an approach
that likely under-represents the pathological burden of soluble
DPR proteins. Moreover, it may be erroneous to assume
that insoluble DPRs that accumulate in cytoplasmic aggregates
represent the most toxic species, since some DPRs are charged
and highly soluble and may be difficult to assess using
traditional immunohistochemistry in fixed, post-mortem tissue.
Furthermore, it may be difficult to visualize the most toxic species
in patient tissues, as degenerating neurons are lost. Nevertheless,
the apparent discrepancy between the burden of DPR-protein
deposition, the levels of which are greatest in the cerebellum, and
the severity of neurodegeneration, which is greatest in the motor
cortex and spinal cord, needs to be resolved to understand the
role of DPR proteins in the development of disease.
GA TOXICITY
Of the five DPR species generated in C9orf72-mediated disease,
the GA DPR is the most readily visible in p62/ubiquitin positive
inclusions in the brain and spinal cord of patients with ALS/FTD
(May et al., 2014; Zhang et al., 2014). Consistent with the
expected biophysical properties of a polymer formed from
poly-GA (see Figure 2), the GA DPR has a strong propensity
to aggregate, forming amyloidogenic fibrils that stain positive
with Congo red or thioflavin T (May et al., 2014; Chang et al.,
2016). These fibrils form a parallel β-sheet structure that is
hypothesized to share similar properties with the structure of
the amyloid-beta peptide present in Alzheimer’s disease (Chang
et al., 2016; Edbauer and Haass, 2016).
Expression of the GA DPR in neuronal cell cultures
leads to reduced dendritic branching, increased endoplasmic
FIGURE 2 | The physico-chemical properties of individual DPR species influence their toxicity leading to cellular impairment. Physico-chemical
properties of amino acids comprising the DPR species in C9orf72 mediated ALS/FTD (top). The structure and charge of individual DPR species and their influence
on their interactions and toxicity (bottom left). Cellular functions known to be impaired by DPR toxicity (bottom right).
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reticulum stress, proteasomal inhibition and apoptosis through
the activation of caspase 3 (May et al., 2014; Zhang et al.,
2014). The GA DPR has been proposed to induce such
cellular toxicity through direct sequestration of proteins, with
direct proteasomal impairment and interaction with Unc119 as
possible primary toxic mechanisms. Supporting this hypothesis,
mass spectrometry analysis revealed that, in addition to p62,
the GA DPR binds Unc119, ubiquilin-1 and -2, and some
proteasomal subunits (May et al., 2014; Schludi et al., 2015).
The GA DPR was found to directly associate with Unc119,
a protein that regulates axonal maintenance and suppresses
axonal branching (Knobel et al., 2001; May et al., 2014).
Overexpression of Unc119 in cortical neurons mitigates toxicity
arising due to expression of the GA DPR whereas knockdown
of Unc119 was sufficient to induce toxicity in the absence
of DPR expression (May et al., 2014). A recently developed
mouse model showed consistent results by expressing high
levels of GA DPR in cortical tissue by adeno-associated viral
transduction. These mice showed motor and cognitive deficits
along with cerebellar atrophy, neural toxicity and astrogliosis
(Chew et al., 2015; Zhang et al., 2016). Consistent with the
toxicity observed in cell cultures, the mice showed sequestration
of the proteasome proteins HR23A and HR23B by the GA DPR.
Overexpression of HR23B partially mitigates poly-GA-induced
toxicity, supporting the contention that sequestration of targets
by the GA DPR is a driving force behind the associated
neurodegeneration.
Although there is general agreement that the GA DPR is
toxic when expressed at high levels, the GA DPR appears
to be less toxic than arginine-containing DPRs (GR and PR)
when compared head-to-head in a common biological system
(Mizielinska et al., 2014; Wen et al., 2014; Freibaum et al.,
2015). Indeed, multiple studies reported little or no toxicity
caused by GA DPR expression (or PA and GP DPR expression
for that matter) in primary neurons or Drosophila models,
but quite potent toxicity of GR and PR DPR expression.
Expression of the GA DPR in these model systems is likely to
be much lower than in viral-mediated expression systems and
may account for the differences in observed toxicity. It remains
to be determined whether the GA DPR is toxic at physiologically
relevant concentrations and conditions.
GR/PR TOXICITY
Studies demonstrating the toxicities of GR and PR DPRs in vitro
and in Drosophila provided initial insight into the toxicity of
these DPRs in C9orf72-mediated ALS/FTD. These DPRs are both
highly charged and polar (Figure 2), tend to accumulate in the
nucleoli of U2OS cells and cause cell death when added directly
to cell culture media at concentrations of less than 10 µM (Kwon
et al., 2014). Notably, the stabilities of these two DPRs are quite
different from one another: the GR DPR is unstable under cell
culture conditions (half-life < 30 min), whereas the PR DPR
is relatively stable (half-life ∼72 h; Kwon et al., 2014). These
DPRs also consistently show toxicity when expressed by plasmid
transfection in several different cell lines, inducing cell death in
HEK293T cells, NSC-34 cells, as well as both cortical and motor
neurons derived from induced pluripotent stem cells (Wen et al.,
2014; Tao et al., 2015; Lee et al., 2016).
In Drosophila, tissue-specific expression of GR and PR via
traditional ATG-mediated translation (using alternative codons
to GGGGCC) is extremely toxic in the eye, neuronal tissue
(neurons and glia) and motor neurons (Mizielinska et al., 2014;
Wen et al., 2014; Freibaum et al., 2015; Lee et al., 2016). In
contrast, expression of GA, PA and GP DPRs is not toxic
in the Drosophila eye. Expression of PA and GP DPRs in
Drosophila neurons is nontoxic, and expression of the GA DPR
leads to only a slight decrease in lifespan (Mizielinska et al.,
2014; Wen et al., 2014; Freibaum et al., 2015; Lee et al., 2016).
Together, these findings suggest that GR and PR, but not the
other DPRs, are highly detrimental to the survival of neurons in
Drosophila.
Notably, two additional Drosophila models of C9orf72 disease
confirmed expression of the GR DPR via RAN translation of a
GGGGCC repeat (Mizielinska et al., 2014; Freibaum et al., 2015).
Insertion of periodic stop codons between the hexanucleotide
repeats eliminated the production of RAN-generated DPRs
and associated toxic phenotypes in Drosophila while retaining
a G-quadruplex RNA structure (Mizielinska et al., 2014).
One interpretation of this finding is that RNA-mediated
toxicity is nonexistent or irrelevant; however, this may be an
over-interpretation because it has not been determined whether
this modified RNA sequence can sequester the same proteins as
can the GGGGCC repeat sequence.
The mechanisms by which GR and PR DPRs induce toxic
phenotypes in neurons have become increasingly understood
in recent years. Recent publications demonstrated that GR and
PR DPRs play a broader role in influencing the formation
of membrane-less organelles and their liquid–liquid phase
separation dynamics (Lee et al., 2016; Lin et al., 2016). In
these studies, initial clues were found by proteomic analysis
of the binding partners of GR and PR DPRs, which revealed
enrichment in proteins that contain a low complexity sequence
domain (LCD) (Lee et al., 2016; Lin et al., 2016). LCDs
are evolutionarily conserved amino acid segments, typically
75–300 amino acids in length and present in up to one-third
of the human proteome, that are compositionally biased in
amino acid representation (Brangwynne et al., 2015). Most
often, LCDs are highly enriched in glycine and serine, with
interspersed aromatic and charged residues, and are predicted
to be unstructured (Huntley and Golding, 2002; Uversky, 2002).
LCDs engage in multivalent, low affinity interactions and over
the past few years it has emerged that LCD interactions are
important for innumerable cellular processes, including the
formation and function of membrane-less organelles such as
the nucleolus, nuclear pore complex, stress granules, nuclear
speckles and Cajal bodies (Brangwynne et al., 2015). These
DPRs were found to associate with low-complexity domains
exclusively in a polymeric conformation suggesting that the
polymeric structure of these DPRs is the primary toxic species
in vivo (Lin et al., 2016). To assess the contribution of LCD
interacting proteins in DPR-mediated toxicity, a Drosophila
model in which expression of a GR DPR results in decreased
viability was utilized (Lee et al., 2016). Using this model for an
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in vivo screen, they used RNA interference to reduce expression
of Drosophila orthologs of the identified GR- and PR-interacting
proteins. Results from this screen demonstrated that reduction of
these interacting proteins either enhanced (21%) or suppressed
(63%) the viability phenotype caused by expression of the
GR DPR.
The most obvious visual association of the GR and PR DPRs
with membrane-less organelles is their nucleolar localization in
cells (Kwon et al., 2014; Wen et al., 2014; Tao et al., 2015;
Lee et al., 2016). PR DPRs are almost exclusively localized
within the nucleolus, whereas GR DPRs are observed both
in the nucleolus and within the cytoplasm (Wen et al., 2014;
Lee et al., 2016). This localization to the nucleolus is not
benign, instead resulting in impaired rRNA synthesis, ribosome
biogenesis and translation (Tao et al., 2015; Kanekura et al., 2016;
Lee et al., 2016). Recent super-resolution fluorescent imaging
of the ultrastructure of the nucleolus revealed that both the
GR and PR DPRs localize to the granular component, the
most distal region of the nucleolus where ribosome assembly
takes place (Boisvert et al., 2007; Lee et al., 2016). In vitro
co-incubation of the GR or PR DPR with nucleophosmin, a
protein found in the granular component of nucleoli, induced a
liquid–liquid phase separation of nucleophosmin and impaired
its interaction with SURF6, an endogenous binding protein (Lee
et al., 2016). In live cells, expression of the GR and PR DPRs
reduced the mobile fractions of proteins that associate with
numerous membrane-less organelles including the nucleolus,
stress granules, nuclear speckles and Cajal bodies.
The alteration of liquid-like properties in nuclear speckles by
GR and PR DPRs provides a potential mechanism by which these
DPRs induce specific splicing alterations in cells (Kwon et al.,
2014; Kanekura et al., 2016). GR and PR DPRs also associate with
TDP-43-positive RNA granules or stress granules in live cells.
Addition of these DPRs causes the granules to become poorly
dynamic, which may drive the fibrillization of ALS-causing
proteins such as hnRNPA2B1 or TDP-43 (Molliex et al., 2015).
Impairment of RNA-granule dynamics by GR and PR DPRs may
also affect the initiation stage of RNA granule formation, as they
appear to prevent stress granule formation, at least in response to
arsenite-induced stress (Tao et al., 2015).
Liquid–liquid phase separation is thought to be the
mechanism by which cargoes are selectively transported
through the nuclear pore (Schmidt and Görlich, 2016). Recently,
several studies have demonstrated that nucleocytoplasmic
transport abnormalities are common in Drosophila and induced
pluripotent stem cell models of C9orf72-mediated ALS/FTD
(Donnelly et al., 2013; Freibaum et al., 2015; Joviˇci´c et al., 2015;
Zhang et al., 2015). Subsequent Drosophila and yeast phenotypic
screens have shown that numerous nuclear pore components
and proteins involved in shuttling either suppress or enhance
the toxicity caused by GR and PR DPRs, suggesting that these
DPRs play a major role in nucleocytoplasmic trafficking defects
(Joviˇci´c et al., 2015; Boeynaems et al., 2016; Lee et al., 2016).
Although it is possible that GR and PR DPRs indirectly mediate
these defects, it is also very likely that the DPRs bind the
nuclear pore and directly alter the phase-separation properties
of cargoes. Indeed, proteomic analysis revealed that several
nuclear pore and trafficking components interact with GR and
PR DPRs (Lee et al., 2016; Lin et al., 2016). These DPRs likely
interact directly with the core of the nuclear pore, as it has been
revealed that the PR DPR can directly interact with and stabilize
polymeric phenylalanine: glycine repeats found within multiple
nucleoporin proteins, thus changing the dynamic properties of
the central channel (Shi et al., 2017).
The relative contribution of GR and PR DPRs to human
disease remains an open question. These two DPRs are much
less stable than are other RAN-translated DPRs, and the half-life
of GR is much shorter than that of PR (Kwon et al., 2014).
Future studies will be needed to determine the dose-dependent
toxicity of GR and PR DPRs (Kwon et al., 2014; Wen et al.,
2014). The in vivo translation rate of these DPRs is also unknown,
and it is possible that the sense and antisense strands of the
hexanucleotide repeat are not translated at comparable rates.
It is also likely that the GR and PR DPRs have distinct and
separate functions in human disease. Proteomic analysis has
shown that ∼40% of the GR and PR interactome is shared
between these two DPR species (Lee et al., 2016). However,
of the total GR and PR interactome, ∼35% of proteins bind
to only the PR DPR, and ∼25% associate with only the
GR DPR. There are also distinct differences in the cellular
localization of the GR and PR DPRs. The concentration of
cytoplasmic GR is greater than that of PR, therefore it is
likely that GR plays a greater role in influencing stress granule
dynamics (Wen et al., 2014; Lee et al., 2016). Additionally,
cytoplasmic GR was found to localize to the mitochondria
and associate with mitochondrial ribosomal proteins leading to
the induction of oxidative stress (Lopez-Gonzalez et al., 2016).
These differences are also reflected in the sub structure of the
nucleolus as super resolution imaging has revealed that PR
distinctly localizes to the granular component of the nucleolus,
whereas GR localizes to both the granular component and the
fibrillar core, the central region of the nucleolus that is critical
for the production or rRNA (Boisvert et al., 2007; Lee et al.,
2016).
Overall, there is strong evidence to suggest that the GR and
PR DPRs significantly contribute to the progression of C9orf72-
mediated ALS/FTD. The development of mammalian models to
study these DPRs is critical to determine the extent to which
these DPRs damage neurons and/or glia. Some insights have
emerged from a recently described transgenic mouse model in
which C9ORF72 with repeat expansions was expressed using
a bacterial artificial chromosome. In this mouse model, motor
deficits and neurodegeneration were highly associated with
detectable expression of the PR DPR, possibly implicating this
species as the most important in disease progression (Liu et al.,
2016).
ROLE OF OTHER DIPEPTIDE REPEATS
AND THE INTERACTION OF MULTIPLE
SPECIES
The GP and PA DPRs are uncharged and have a compact flexible
coil structure (Figure 2). Consistent with these biophysical
properties, these DPRs appear to be relatively inert compared
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with the other C9orf72 DPR species. In HEK293T and HeLa cells,
these DPRs did not appear to alter the subcellular localization
of GFP, and mass spectrometry analysis revealed that they do
not substantially interact with endogenous cellular proteins (Lee
et al., 2016). These species are nontoxic in Drosophila models,
although the GP DPR localizes to discrete cytoplasmic and
nuclear foci in a Drosophila model expressing GGGGCC repeats
(Mizielinska et al., 2014; Wen et al., 2014; Freibaum et al., 2015;
Lee et al., 2016). Additionally, the GP DPR inhibits degradation
of a reporter used to assay the functionality of the ubiquitin-
proteasome system and increases cell death in the presence of the
proteasome inhibitor MG-132 (Yamakawa et al., 2015).
A currently underrepresented area of study in the C9orf72-
mediated ALS/FTD field is the interaction of individual DPRs
with each other. An initial analysis in Neuro2A cells suggested
that GR and PR DPRs recruit both GA and GP DPRs into
inclusions (Yamakawa et al., 2015). The interaction between GR
and GA DPRs occurs in Drosophila, HeLa cells and neurons, and
the GR DPR accumulates in cytoplasmic GA DPR containing
aggregates. Additionally, expression of the GA DPR mitigates
wing abnormalities caused by overexpression of the GR DPR in
Drosophila (Yang et al., 2015). It is unclear whether the GR DPR
affects the sequestration of proteasomal proteins into GA DPR
aggregates and whether the PR DPR is also sequestered into GA
DPR aggregates. Questions regarding how the five DPR species
interact with each other in vivo and whether these interactions
are mitigating, synergistic, or dynamic (i.e., changing throughout
the course of DPR expression and disease progression) remain
unanswered.
FAR-REACHING IMPLICATIONS OF DPR
PRODUCTION IN DEGENERATIVE
DISEASE
It is well established that DPRs can induce toxicity in neurons,
although the extent to which DPRs play a role in the pathogenesis
of C9orf72-mediated disease remains controversial. A summary
of what is known about the structures, physico-chemical
properties, interactomes and toxic mechanisms of individual
DPR species is summarized in Figure 2. It is possible that these
toxic mechanisms of DPR expression directly lead to neuronal
cell death. However, it is also likely that a number of downstream
effectors mediate the process of neuronal death, either directly
or indirectly. One likely effector of DPR expression is TDP-43,
a major disease protein found in ALS/FTD that was also found
to interact with the GR and PR DPRs (Neumann et al., 2006;
Lee et al., 2016). Future examination of DPR models, both
in vitro and in vivo will likely yield additional effectors of DPR
toxicity.
There are many open questions concerning DPR pathology.
It remains to be determined what size DPRs are found
in diseased neurons, however it is likely that toxicity is
proportional to repeat length as Drosophila and yeast models
have revealed that toxicity increases as repeat length increases
(Mizielinska et al., 2014; Freibaum et al., 2015; Joviˇci´c et al.,
2015). Second, it is currently unknown if DPR toxicity is
generated in a strictly cell autonomous manner via RAN
translation (Mori et al., 2013a,c; Zu et al., 2013). Indeed,
a recent publication demonstrated that transmission of all
five DPR species can occur through cell-to-cell spreading in
neuronal cultures including IPS derived motor neurons. This
transmission was found to occur in both the anterograde and
retrograde directions via vesicle dependent and independent
mechanisms (Westergard et al., 2016). Additionally, it has
yet to be determined whether DPR production in glial cells
contributes to their toxicity in human disease (Schludi et al.,
2015).
An area that requires greater attention is the interplay of DPRs
and RNA, specifically with the sense and antisense strands of the
hexanucleotide repeats. Of particular interest is the contribution
of such interactions to the sequestration of endogenous proteins
that are essential for neuronal cell survival. Specifically, both
the hexanucleotide repeat RNA and DPRs sequester proteins
that are enriched in low-complexity domains and play critical
roles in the formation of non-membrane-bound organelles and
RNA metabolism (Donnelly et al., 2013; Mori et al., 2013b;
Haeusler et al., 2014; Conlon et al., 2016). One example is the
sequestration of nucleolin, which associates with both GGGGCC
RNA and the GR and PR DPRs (Haeusler et al., 2014). At
present, it is unclear if these sequestered proteins associate
with both DPRs and hexanucleotide RNA together in a single
complex.
Another open question is how the noncoding hexanucleotide
sequences undergo translation. It has been proposed that
RAN translation is activated by a hairpin structure formed
by the repetitive RNA (Cleary and Ranum, 2013). However,
it is unclear how this noncoding RNA is exported for
translation while avoiding degradation by the nuclear exosome.
One hypothesis is that the accumulation of RNA foci may
overwhelm the degradation machinery of the exosome, thereby
allowing the export of the RNAs for translation. In support
of this hypothesis, knockdown of exosomal subunits by
RNA interference enhances toxicity in a transgenic C9orf72
Drosophila model (Freibaum et al., 2015). Alternatively, or
perhaps synergistically, the breakdown of the nuclear pore
architecture and defects in nucleocytoplasmic shuttling may
lead to leakiness of hexanucleotide repeat RNA from the
nucleus into the cytoplasm, where they undergo RAN translation
(Freibaum et al., 2015; Joviˇci´c et al., 2015; Zhang et al.,
2015, 2016; Boeynaems et al., 2016). Consistent with this
hypothesis, cells expressing the expanded hexanucleotide repeat
were observed to accumulate excess nuclear RNA (Freibaum
et al., 2015; Rossi et al., 2015). This impaired nuclear
shuttling may lead to a feed-forward process in which the
RAN-generated DPRs are produced with increasingly greater
efficiency.
Understanding the interplay between the hexanucleotide
repeat RNA and GA, GR and/or PR DPRs will be critical
to elucidate the mechanism and temporal process by which
neurons die in C9orf72-mediated disease. To summarize what is
known about the pathogenic steps that occur during C9orf72-
mediated disease progression, we propose the following model:
(1) an initial buildup of stable and toxic hexanucleotide
G-quadruplex RNA leads to a signaling cascade that leads to
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the production of RAN DPRs; (2) because the GA DPR is
the most stable and abundant species of DPR produced, it
most likely plays a primary role in proteasomal inhibition;
and (3) finally, the inhibition of the proteasome and further
breakdown of nucleocytoplasmic shuttling leads to accumulation
of GR and PR DPRs, thereby altering the dynamics of non-
membrane-bound organelles and ultimately leading to neuronal
death. The association of the GR and PR DPR with a large
number of LCDs illuminates how such a vast and disparate
array of cellular defects has been observed (see Figure 2).
Additionally, it suggests a convergence in mechanisms between
DPRs that interact with LCDs leading to alterations in phase
dynamics vs. toxicity initiated by disease-causing mutations that
directly impact the phase dynamics of specific disease initiating
proteins.
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